# LLM Judge — Argo claude-sonnet-4-6

- Coverage: C1 tested directly (ANI values); C2 tested (AMR genes); C3 tested (ANI clustering); C4 not tested (PathogenFinder not run)

- Agreement:
  - C1: ANI values match paper's reported values closely — ISS vs EB-247T ~98.62-98.63% (paper: 98.66%), ISS vs 153_ECLO ~98.62-98.70% (paper: 98.73%), ISS vs MBRL-1077 ~95.53-95.58% (paper: 95.26%), within-ISS ~99.99-100% (paper: ~100%). All within rounding/tool-version noise.
  - C2: MDR gene profile confirmed — blaACT (beta-lactamase), oqxA/oqxB (efflux pumps), fosA present in all ISS isolates. marA/B/C/R MAR operon not detected by AMRFinderPlus (possible database/tool difference from original CARD/ResFinder analysis), but overall MDR characterization supported.
  - C3: ANI clustering confirmed — ISS strains cluster tightly with EB-247T and 153_ECLO (~98.6%), clearly more distant from MBRL-1077 (~95.5%), consistent with paper's claim.
  - C4: Not tested.

- Notable divergences:
  - ANI values differ by <0.3% from paper's reported values — within expected variation from tool versions and fragment parameters; not meaningful.
  - marA/B/C/R MAR operon absent from AMRFinderPlus results; paper likely used different AMR database (CARD/ResFinder). This is a tool-database difference, not a biological contradiction, but represents a gap in C2 replication.
  - MBRL-1077 carries additional resistance genes (blaIMI-1 carbapenemase, qnrE) not highlighted in paper's ISS comparison, consistent with paper's framing of it as more divergent.

- Verdict: REPLICATED

- One-line justification: ANI values and AMR gene profiles closely match paper's core claims C1–C3 within tool/database variation; no meaningful contradictions found.
